HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 203 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $166,026 | -11.8% | 4,718 | +38.1% | 0.01% | -21.4% |
Q4 2022 | $188,277 | +5.2% | 3,417 | -15.7% | 0.01% | 0.0% |
Q3 2022 | $179,000 | +5.9% | 4,052 | +16.6% | 0.01% | -12.5% |
Q2 2022 | $169,000 | -66.7% | 3,476 | -66.7% | 0.02% | -63.6% |
Q1 2022 | $507,000 | +525.9% | 10,427 | +448.8% | 0.04% | +528.6% |
Q4 2021 | $81,000 | – | 1,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |